<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
Report by Issuer of Securities Quoted on NASDAQ
Interdealer Quotation System
Filed pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 and Rule 13a-17
or 15d-17 thereunder
Life Medical Sciences, Inc.
________________________________________________________________________________
(Exact name of issuer as specified in charter)
214 Carnegie Center, Princeton, NJ 08540
________________________________________________________________________________
(Address of principal executive offices)
Issuer's telephone number, including area code (609) 452-0707
---------------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the number of
shares outstanding:
1. Title of security Common Stock, $.001 par value
-----------------------------------------------------------
2. Number of shares outstanding before the change 5,450,320
-------------------------------
3. Number of shares outstanding after the change 7,450,320
--------------------------------
4. Effective date of change May 8, 1996
----------------------------------------------------
5. Method of change: Specify method (such as merger, acquisition, exchange,
distribution, stock split, reverse split, acquisition of stock for
treasury, etc.)
Public Offering of Securities
--------------------------------------------------------------------------------
Give brief description of transaction Registered public offering of
----------------------------------
2,000,000 shares of Common Stock
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change N/A
--------------------------------------------------------
2. Name after change N/A
-----------------------------------------------------------
3. Effective date of charter amendment changing name N/A
---------------------------
4. Date of shareholder approval of change, if required N/A
-------------------------
Date May 17,1996
-----------
By:/s/ Donald Fallon
----------------------
Name: Donald Fallon
Title: Vice President and Chief
Financial Officer
